Evidence map›Paper›PMID 40167522›Full record

ArticleChembiochem : a European journal of chemical biology2025

SAAP-148 Oligomerizes into a Hexamer Forming a Hydrophobic Inner Core.

Aden Hodzic, Djenana Vejzovic, Altea Topciu, Kirill Kuhlmann, Raj Kumar, Maria Andrea Mroginski, Alejandra de Miguel, Pia Hofmann, Klaus Zangger, Markus Weingarth and 6 more

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. AlphaFold3: An Overview of Applications and Performance Insights.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Aden HodzicNanoEntum, Ruckerlbergergürtel 10, 8010, Graz, Austria.
Djenana VejzovicInstitute of Molecular Biosciences, University of Graz, 8010, Graz, Austria.
Altea TopciuInstitute of Molecular Biosciences, University of Graz, 8010, Graz, Austria.
Kirill KuhlmannInstitute of Molecular Biosciences, University of Graz, 8010, Graz, Austria.ORCID https://orcid.org/0000-0001-9577-0742
Raj KumarNMR Spectroscopy, Department of Chemistry, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Maria Andrea MroginskiInstitut für Chemie, Technische Universität Berlin, Straße des 17. Juni 115, 10623, Berlin, Germany.
Alejandra de MiguelInstitut für Chemie, Technische Universität Berlin, Straße des 17. Juni 115, 10623, Berlin, Germany.
Pia HofmannInstitute of Chemistry/Organic and Bioorganic Chemistry, University of Graz, 8010, Graz, Austria.
Klaus ZanggerInstitute of Chemistry/Organic and Bioorganic Chemistry, University of Graz, 8010, Graz, Austria.
Markus WeingarthNMR Spectroscopy, Department of Chemistry, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Robert A CordfunkeDepartment of Immunology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands.
Jan W DrijfhoutDepartment of Immunology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands.
Peter NibberingLaboratory of Infectious Diseases, Leiden University Center of Infectious Diseases (LU-CID) Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands.
Michal BelickaInstitute of Molecular Biosciences, University of Graz, 8010, Graz, Austria.
Karl LohnerInstitute of Molecular Biosciences, University of Graz, 8010, Graz, Austria.
Nermina MalanovicInstitute of Molecular Biosciences, University of Graz, 8010, Graz, Austria.ORCID https://orcid.org/0000-0002-2903-9369

Funding

Austrian Science Fund FWF 10.55776/DOC130Austrian Science Fund FWF 10.55776/P36985Austrian Society for Antimicrobial ChemotherapyDeutsche Forschungs-gemeinschaft EXC2008-390540038European Community's Seventh Framework Program n° 278890University of Graz
6 · The paper itself

Abstract

Human cathelicidin LL-37 derivative, the 24-mer SAAP-148, is highly effective in vitro in eradicating multidrug-resistant bacteria without inducing resistance. SAAP-148 has a high cationic charge (+11) and 46% hydrophobicity, which, once the peptide folds into an alpha helix, forms a wide hydrophobic face. This highly amphipathic nature facilitates on the one hand its insertion into the membrane's fatty acyl chain region and on the other hand it´s interaction with anionic membrane components, which aids in killing bacteria. However, the contributions of the secondary and quaternary structures have not been thoroughly investigated so far. To address this, we applied circular dichroism, NMR spectroscopy, X-ray scattering, AlphaFold 3 protein folding software, and molecular dynamics simulations. Our results reveal that SAAP-148 adopts a stable hexameric bundle composed of three parallel dimers, that together form a hydrophobic core of aromatic side chain residues. The hexameric structure is retained at the membrane interface, whereby, MD simulation studies indicated the formation of a fiber-like structure in the presence of anionic membranes. This certainly seems plausible, as oligomers are stabilized by aromatic residues, and the exposure of positively charged side chains on the surface likely facilitates the transition of the peptide into fibrils on anionic membranes.

Indexed as

Antimicrobial Cationic PeptidesCathelicidinsHumansHydrophobic and Hydrophilic InteractionsMolecular Dynamics SimulationProtein MultimerizationAntimicrobial Cationic PeptidesCathelicidinsantimicrobial peptideshydrophobic coreslipid–peptide interactionspeptide aggregatesSAAP‐148

Identifiers

PMID40167522
PMCPMC12177698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.